Metraipolis › archive › dc_e9820168d990

P7C3 Compounds as Targeted Mitochondrial Therapeutics for Brain Disorders — Europe PMC PMID:42698301

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42698301
DOI
10.1002/cns.71139
License (as archived)
solo-consultazione
Archived
2026-10-16T12:30:08.062Z
SHA-256 of the archived text
5e05a3241b29e5f5e15b72d2387092083643a4ee442bc6c3f32defbb0f905283
Stable URL of this page
https://metraipolis.com/documento/dc_e9820168d990

How to cite

P7C3 Compounds as Targeted Mitochondrial Therapeutics for Brain Disorders — Europe PMC PMID:42698301 — Europe PMC (en), https://europepmc.org/article/MED/42698301 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e9820168d990 (Metraipolis archive dc_e9820168d990, sha256 5e05a3241b29e5f5e15b72d2387092083643a4ee442bc6c3f32defbb0f905283)
BibTeX
@misc{dce9820168d990,
  title = {P7C3 Compounds as Targeted Mitochondrial Therapeutics for Brain Disorders — Europe PMC PMID:42698301},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42698301},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e9820168d990; sha256 5e05a3241b29e5f5e15b72d2387092083643a4ee442bc6c3f32defbb0f905283},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42698301. Agents can read the archived copy with the MCP tool read_document.